Novel Targeted Therapies for T-Cell Malignancies

被引：0

作者：

Tesio, Melania ^{[1
]}

机构：

[1] Ctr Int Rech Infectiol CIRI, UR LIB Lymphoma Immune Biol INSERM U111, F-69007 Lyon, France

来源：

CANCERS | 2022年 / 14卷 / 16期

关键词：

PHASE-II; LYMPHOMA; PTEN; BLOCKADE; NOTCH1; PD-1;

D O I：

10.3390/cancers14163955

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 39 条

[1] Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts
Agnusdei, V.
Minuzzo, S.
Frasson, C.
Grassi, A.
Axelrod, F.
Satyal, S.
Gurney, A.
Hoey, T.
Seganfreddo, E.
Basso, G.
Valtorta, S.
Moresco, R. M.
Amadori, A.
Indraccolo, S.
[J]. LEUKEMIA, 2014, 28 (02) : 278 - 288
[2] CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells
Alcantara, Marion
Tesio, Melania
June, Carl H.
Houot, Roch
[J]. LEUKEMIA, 2018, 32 (11) : 2307 - 2315
[3] The aggressive peripheral T-cell lymphomas: 2017
Armitage, James O.
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (07) : 706 - 715
[4] Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
Coiffier, Bertrand
Pro, Barbara
Prince, H. Miles
Foss, Francine
Sokol, Lubomir
Greenwood, Matthew
Caballero, Dolores
Borchmann, Peter
Morschhauser, Franck
Wilhelm, Martin
Pinter-Brown, Lauren
Padmanabhan, Swaminathan
Shustov, Andrei
Nichols, Jean
Carroll, Susan
Balser, John
Balser, Barbara
Horwitz, Steven
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) : 631 - 636
[5] The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome
da Silva Almeida, Ana Carolina
Abate, Francesco
Khiabanian, Hossein
Martinez-Escala, Estela
Guitart, Joan
Tensen, Cornelis P.
Vermeer, Maarten H.
Rabadan, Raul
Ferrando, Adolfo
Palomero, Teresa
[J]. NATURE GENETICS, 2015, 47 (12) : 1465 - +
[6] Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALL
El Chaer, F.
Holtzman, N.
Binder, E.
Porter, N. C.
Singh, Z. N.
Koka, M.
Rapoport, A. P.
Emadi, A.
[J]. BONE MARROW TRANSPLANTATION, 2017, 52 (11) : 1583 - 1584
[7] The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia
Espinosa, Lluis
Cathelin, Severine
D'Altri, Teresa
Trimarchi, Thomas
Statnikov, Alexander
Guiu, Jordi
Rodilla, Veronica
Ingles-Esteve, Julia
Nomdedeu, Josep
Bellosillo, Beatriz
Besses, Carles
Abdel-Wahab, Omar
Kucine, Nicole
Sun, Shao-Cong
Song, Guangchan
Mullighan, Charles C.
Levine, Ross L.
Rajewsky, Klaus
Aifantis, Iannis
Bigas, Anna
[J]. CANCER CELL, 2010, 18 (03) : 268 - 281
[8] Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
Foss, Francine
Horwitz, Steven
Pro, Barbara
Prince, H. Miles
Sokol, Lubomir
Balser, Barbara
Wolfson, Julie
Coiffier, Bertrand
[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
[9] T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma
Ghione, Paola
Faruque, Promie
Mehta-Shah, Neha
Seshan, Venkatraman
Ozkaya, Neval
Bhaskar, Shakthi
Yeung, James
Spinner, Michael A.
Lunning, Matthew
Inghirami, Giorgio
Moskowitz, Alison
Galasso, Natasha
Ganesan, Nivetha
van der Weyden, Carrie
Ruan, Jia
Prince, H. Miles
Trotman, Judith
Advani, Ranjana
Dogan, Ahmet
Horwitz, Steven
[J]. BLOOD ADVANCES, 2020, 4 (19) : 4640 - 4647
[10] High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
Gutierrez, Alejandro
Sanda, Takaomi
Grebliunaite, Ruta
Carracedo, Arkaitz
Salmena, Leonardo
Ahn, Yebin
Dahlberg, Suzanne
Neuberg, Donna
Moreau, Lisa A.
Winter, Stuart S.
Larson, Richard
Zhang, Jianhua
Protopopov, Alexei
Chin, Lynda
Pandolfi, Pier Paolo
Silverman, Lewis B.
Hunger, Stephen P.
Sallan, Stephen E.
Look, A. Thomas
[J]. BLOOD, 2009, 114 (03) : 647 - 650

← 1 2 3 4 →